| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 12.906 | 35.773 | 26.674 | 38.103 |
| Total Income - EUR | - | - | - | - | - | - | 12.906 | 35.774 | 46.891 | 38.104 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.923 | 8.163 | 30.872 | 19.705 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 10.982 | 27.610 | 16.019 | 18.400 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 10.595 | 26.687 | 13.528 | 15.590 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Doublesweet Healthcare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 25.588 | 24.811 | 18.560 |
| Current Assets | - | - | - | - | - | - | 11.023 | 5.094 | 14.512 | 13.834 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 1.386 | 3.126 | 12.026 | 9.350 |
| Cash | - | - | - | - | - | - | 9.637 | 1.968 | 2.486 | 4.484 |
| Shareholders Funds | - | - | - | - | - | - | 8.507 | 29.137 | 22.360 | 1.639 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 2.516 | 1.545 | 16.964 | 30.755 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Doublesweet Healthcare S.r.l.